Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2022-11-30 Report Publication Anno…
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
11302590.pdf
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1501 characters) from Biohit Oyj detailing the scheduled dates for the release of their 2022 financial statements, annual report, and 2023 interim reports, as well as the planned date for the Annual General Meeting. It does not contain the actual financial reports or meeting materials, but rather serves as a calendar/schedule announcement for upcoming publications. Therefore, it falls under the 'Report Publication Announcement' (RPA) category.
2022-11-30 Finnish
Biohit Oyj:n taloudellinen tiedottaminen ja yhtiökokous vuonna 2023
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2544 characters) from Biohit Oyj detailing the scheduled dates for the release of their financial reports (annual and interim) and the date for their annual general meeting for the year 2023. It does not contain the actual financial results or the meeting materials themselves, but rather serves as a calendar/schedule announcement. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2022-11-30 Finnish
Biohit Oyj's Financial Reporting and Annual General Meeting in 2023
Report Publication Announcement Classification · 99% confidence The document text is an announcement detailing the schedule for various corporate reports and meetings for Biohit Oyj in 2023. It explicitly mentions the release dates for the 'financial statements for 2022', the 'Annual report', the 'Half year financial report', and the planned date for the 'Annual General Meeting'. Since the document itself is not the full financial report (10-K, IR) or the AGM presentation (AGM-R), but rather an announcement about when these events/reports will occur, it fits best under the category for announcing the publication of reports. The document states when the Annual Report and Financial Statements will be published, which aligns with the purpose of a Report Publication Announcement (RPA).
2022-11-30 English
11291643.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a stock exchange release from Biohit Oyj announcing the board's decision to implement a new stock option program for key personnel. This involves the issuance of option rights that entitle holders to subscribe for company shares. According to the filing definitions, announcements regarding new share issues, stock splits, or capital changes (including option programs that lead to future share issuance) fall under the 'Share Issue/Capital Change' (SHA) category.
2022-11-29 Finnish
Biohit Oyj:n hallitus päätti uudesta optio-ohjelmasta
Share Issue/Capital Change Classification · 95% confidence The document is a stock exchange release from Biohit Oyj announcing the board's decision to implement a new stock option program for key personnel. This involves the issuance of option rights that allow for the future subscription of company shares. According to the filing definitions, announcements regarding new share issues, stock splits, or capital changes (including option programs that lead to potential share issuance) fall under the 'Share Issue/Capital Change' category.
2022-11-29 Finnish
11291667.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a stock exchange release announcing a new option scheme for key personnel (CFO and Head of Technical Product Management) approved by the Board of Directors. While it involves management, it specifically details the issuance of option rights, which relates to capital structure and share-based compensation. Since it describes the creation of new option rights that entitle holders to subscribe to class B-shares, it falls under the category of share issues or capital changes.
2022-11-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.